Jelle Jacobs

Jelle Jacobs

Auto-generated profile, based on publicly available information

Jelle Jacobs

Laboratory of Multi-Omic Integrative Bioinformatics, Department of Genetics, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2019 in Science
Verified
Journal Article
Closed access
PDF file
IMIván M. Moya
Iván M. Moya
SCStéphanie A. Castaldo
Stéphanie A. Castaldo
LMLaura Van Den Mooter
Laura Van Den Mooter
SSSoheil Soheily
Soheil Soheily
LSLeticia Sansores-Garcia
Leticia Sansores-Garcia
GHGeorg Halder
Georg Halder
Mixed signals at tumor margins: The Hippo signaling pathway has been implicated in tumor growth, sparking interest in the pathway as a potential therapeutic target. In a study of liver cancer in genetically manipulated mice, Moya et al. discovered that the role of this pathway in tumorigenesis is more complex than previously appreciated. They confirmed that activation of the Hippo pathway within tumor cells drives tumor growth; however, they also found that activation of the pathway in adjacent healthy cells has the opposite effect, suppressing tumor growth. Whether tumor cells survive or are eliminated thus appears to depend on competing signals produced by the tumor and surrounding tissue. Science , this issue p. 1029

4 June 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JJJelle Jacobs
Jelle Jacobs
Mardelle AtkinsMardelle Atkins
Mardelle Atkins
KDKristofer Davie
Kristofer Davie
HIHana Imrichova
Hana Imrichova
LRLucia Romanelli
Lucia Romanelli
SAStein Aerts
Stein Aerts

13 February 2015 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
KDKristofer Davie
Kristofer Davie
JJJelle Jacobs
Jelle Jacobs
Mardelle AtkinsMardelle Atkins
Mardelle Atkins
DPDelphine Potier
Delphine Potier
VCValerie Christiaens
Valerie Christiaens
SAStein Aerts
Stein Aerts
Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of transcription factors (TFs). When TFs are bound to active regulatory regions, they displace canonical nucleosomes, making these regions biochemically detectable as nucleosome-depleted regions or accessible/open chromatin. Here we ask whether open chromatin profiling can be used to identify the entire repertoire of active promoters and enhancers underlying tissue-specific gene expression during normal development and oncogenesis in vivo. To this end, we first compare two different approaches to detect open chromatin in vivo using the Drosophila eye primordium as a model system: FAIRE-seq, based on physical separation of open versus closed chromatin; and ATAC-seq, based on preferential integration of a transposon into open chromatin. We find that both methods reproducibly capture the tissue-specific chromatin activity of regulatory regions, including promoters, enhancers, and insulators. Using both techniques, we screened for regulatory regions that become ectopically active during Ras-dependent oncogenesis, and identified 3778 regions that become (over-)activated during tumor development. Next, we applied motif discovery to search for candidate transcription factors that could bind these regions and identified AP-1 and Stat92E as key regulators. We validated the importance of Stat92E in the development of the tumors by introducing a loss of function Stat92E mutant, which was sufficient to rescue the tumor phenotype. Additionally we tested if the predicted Stat92E responsive regulatory regions are genuine, using ectopic induction of JAK/STAT signaling in developing eye discs, and observed that similar chromatin changes indeed occurred. Finally, we determine that these are functionally significant regulatory changes, as nearby target genes are up- or down-regulated. In conclusion, we show that FAIRE-seq and ATAC-seq based open chromatin profiling, combined with motif discovery, is a straightforward approach to identify functional genomic regulatory regions, master regulators, and gene regulatory networks controlling complex in vivo processes. The functional expression of all genes is regulated by proteins, namely transcription factors that bind to specific areas of DNA known as regulatory regions. Whereas most DNA in our genome is normally bound by other proteins (histones) and packaged into units called nucleosomes, a specific subset of tissue-specific regulatory regions is responsible for tissue-specific gene expression; these active regions are nucleosome-depleted and bound by transcription factors. We use two techniques to identify these open chromatin regions, in a normal tissue and a RasV12 induced cancer tissue. We discovered a remarkable change in the accessible regulatory landscape between these two tissues, with several thousand regions becoming more accessible in the cancer tissue. We identified two transcription factors known to be involved in cancer (AP-1 and Stat92E) controlling these newly accessible regulatory regions. Finally, we introduced a mutation resulting in Stat92E becoming non-functional in the cancer tissue, which decreased the severity of the tumor. Our study shows that open chromatin profiling can be used to identify complex in vivo processes, and we shed new light on Ras dependent cancer development.

1 August 2016 in Current Biology
Verified
Journal Article
Closed access
Mardelle AtkinsMardelle Atkins
Mardelle Atkins
DPDelphine Potier
Delphine Potier
LRLucia Romanelli
Lucia Romanelli
JJJelle Jacobs
Jelle Jacobs
JMJana Mach
Jana Mach
GHGeorg Halder
Georg Halder

18 November 2022 in Science
Verified
Journal Article
Closed access
WKW. Kowalczyk
W. Kowalczyk
LRL. Romanelli
L. Romanelli
Mardelle AtkinsMardelle Atkins
Mardelle Atkins
HHHanne Hillen
Hanne Hillen
CGC. Bravo González-Blas
C. Bravo González-Blas
GHGeorg Halder
Georg Halder
The Hippo signaling pathway is widely considered a master regulator of organ growth because of the prominent overgrowth phenotypes caused by experimental manipulation of its activity. Contrary to this model, we show here that removing Hippo transcriptional output did not impair the ability of the mouse liver and Drosophila eyes to grow to their normal size. Moreover, the transcriptional activity of the Hippo pathway effectors Yap/Taz/Yki did not correlate with cell proliferation, and hyperactivation of these effectors induced gene expression programs that did not recapitulate normal development. Concordantly, a functional screen in Drosophila identified several Hippo pathway target genes that were required for ectopic overgrowth but not normal growth. Thus, Hippo signaling does not instruct normal growth, and the Hippo-induced overgrowth phenotypes are caused by the activation of abnormal genetic programs.

1 September 2017 in Developmental Cell
Verified
Journal Article
Closed access
JPJustine Pascual
Justine Pascual
JJJelle Jacobs
Jelle Jacobs
LSLeticia Sansores-Garcia
Leticia Sansores-Garcia
MNMalini Natarajan
Malini Natarajan
JZJulia Zeitlinger
Julia Zeitlinger
FHFisun Hamaratoglu
Fisun Hamaratoglu